Abstract
There is no firm evidence that any one catecholamine is more effective or safer than other in the treatment of shock. The choice of an agent depends on the underlying hemodynamic state. Understanding the pathophysiology, metabolic effects and altered responsiveness to catecholamines during critical illness is useful for management of the same. Titration of catecholamine is essential to avoid harmful side-effects.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
